Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wyandotte Chemicals Corporation was a prominent American chemical manufacturer based in Wyandotte, Michigan, formed in 1943 through the merger of Michigan Alkali Company and J.B. Ford Company. The company is highly significant to the life sciences for its invention and commercialization of Pluronic polyols, a class of non-ionic block copolymers now widely known as poloxamers. These materials became essential surfactants, stabilizers, and drug delivery vehicles used extensively in pharmaceutical formulations and biotechnology applications, such as cell culture media. In 1969, the company was acquired by the German chemical giant BASF, which integrated Wyandotte's operations to significantly expand its presence in the North American market. Today, the legacy of Wyandotte Chemicals persists through the continued industrial and medical utility of the specialty surfactant technologies it pioneered.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wyandotte Chemical.